In glioma cells, the impact of DNA methylation on ATIP1 expression was shown by decitabine treatment, which leads to elevated ATIP1 levels in all glioma cells and low passage GSC (Figure 2c–e). Here, MTUS1 is linked to central nervous system cancer.